PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1988981
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1988981
According to Stratistics MRC, the Global Anxiety & Behaviour Support Products Market is accounted for $2.1 billion in 2026 and is expected to reach $4.5 billion by 2034 growing at a CAGR of 9.8% during the forecast period. Anxiety & Behaviour Support Products are interventions for pets designed to reduce stress, aggression, or fear-related behaviors. They include calming treats, pheromone diffusers, wearable devices, behavioral training aids, and interactive toys. These products support mental health, improve owner-pet relationships, and enhance quality of life. Increasing awareness of pets' emotional wellbeing, the rise of urban living, and behavioral issues due to separation or environmental changes drive market growth. Integration of natural ingredients, smart monitoring, and veterinary guidance enhances efficacy, safety, and adoption of these support products.
Increasing awareness of pet mental health
Pet owners are increasingly recognizing stress, separation anxiety, and behavioural issues in their pets. Rising humanization of pets has led to greater emphasis on emotional well-being alongside physical health. Social media and veterinary campaigns are amplifying awareness about calming solutions. Owners are more willing to invest in supplements, treats, and devices that improve behavioural balance. This heightened focus on mental health continues to fuel market expansion globally.
Limited clinical evidence for efficacy
Many calming treats and supplements lack standardized trials to prove consistent results. Skepticism among veterinarians and pet owners slows adoption in certain regions. Regulatory bodies demand stronger evidence before approving new formulations. This gap between consumer demand and scientific validation creates uncertainty in the market. As a result, limited clinical backing continues to hinder broader acceptance.
AI-based behavioral monitoring devices
Smart collars and wearable trackers can monitor stress indicators such as heart rate and activity levels. AI algorithms provide personalized recommendations for calming routines and supplements. Integration with mobile apps allows owners to track behavioural patterns in real time. Veterinary clinics can use these insights to design tailored treatment plans. This technological innovation is expected to accelerate premium adoption and strengthen market credibility.
Regulatory restrictions on supplements
Authorities in different regions impose strict guidelines on pet supplements, limiting product launches. Variations in approval processes across countries create barriers for global expansion. Companies face delays and added costs in meeting compliance standards. Mislabeling or exaggerated claims can lead to product recalls, damaging brand reputation. This regulatory complexity continues to challenge the industry's growth trajectory.
The Covid-19 pandemic had mixed effects on the anxiety and behaviour support products market. On one hand, supply chain disruptions affected production and distribution of calming supplements and devices. On the other hand, increased pet adoption during lockdowns boosted demand for behavioural support solutions. Owners spending more time at home became more attentive to their pets' emotional needs. Online sales channels grew rapidly as physical retail faced restrictions. Overall, the pandemic accelerated digital adoption while highlighting supply chain vulnerabilities.
The calming treats segment is expected to be the largest during the forecast period
The calming treats segment is expected to account for the largest market share during the forecast period as they are convenient, widely available, and easy to administer. Pet owners prefer treats over supplements due to their palatability and functional benefits. Manufacturers are innovating with natural ingredients such as chamomile, valerian root, and hemp extracts. Retail penetration of calming treats is higher compared to other behavioural support products. Rising awareness of stress management in pets further strengthens demand for this segment.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate due to increasing reliance on professional guidance for behavioural issues. Clinics are integrating calming supplements and monitoring devices into treatment plans. Rising awareness campaigns by veterinarians are boosting consumer trust in these products. Clinics also serve as distribution hubs, enhancing product visibility and credibility. Personalized recommendations from veterinary professionals encourage premium adoption.
During the forecast period, the North America region is expected to hold the largest market share owing to high pet ownership rates and strong purchasing power. Consumers in the U.S. and Canada are highly receptive to behavioural support products. Established brands and veterinary networks are driving adoption of calming treats and supplements. Retail penetration of premium products is higher in North America compared to other regions. Strong awareness campaigns and digital marketing further support growth. These factors collectively ensure North America's dominance in market share.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by rising awareness of pet mental health and supportive regulatory frameworks. Countries such as Germany, France, and the UK are witnessing increased demand for behavioural support solutions. European consumers are highly receptive to natural and eco-friendly calming products. Veterinary endorsements and clinical trials are strengthening credibility in the region. Local startups are entering the market with innovative AI-based monitoring devices.
Key players in the market
Some of the key players in Anxiety & Behaviour Support Products Market include Nestle Purina PetCare, Mars Petcare, Ceva Sante Animale, Zylkene (Vetoquinol), ThunderShirt, Adaptil (Ceva), Pet Naturals of Vermont, VetriScience Laboratories, Rescue Remedy Pets, HempMy Pet, Honest Paws, Bach Flower Remedies, PetHonesty, NaturVet and Only Natural Pet.
In November 2025, Purina Pro Plan Veterinary announced a partnership with Ease, an online platform for veterinary behaviour specialty care. This collaboration gives veterinary clinics free access to board-certified behaviourists, expanding Purina's support mission to address pet anxiety and behavioural challenges through professional guidance.
In November 2025, Ceva unveiled its Douxo Spa product line for pets during the holiday season. While primarily a dermatology and wellness product, it complements Ceva's behavioural support portfolio by addressing comfort and wellbeing, which are closely linked to stress reduction in pets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.